No retraction, correction or concern found when last checked on Oct 17, 2026.
Why are RNA virus mutation rates so damn high?
Siobain Duffy
PLOS Biology · 2018 · Review · CC BY
doi:10.1371/journal.pbio.3000003
Abstract
The high mutation rate of RNA viruses is credited with their evolvability and virulence. This Primer, however, discusses recent evidence that this is, in part, a byproduct of selection for faster genomic replication.
Full text
From PubMed Central, U.S. National Library of Medicine, as current on Oct 17, 2026. Paragraph numbers are ours, so an answer can point at one.
RNA viruses have high mutation rates—up to a million times higher than their hosts—and these high rates are correlated with enhanced virulence and evolvability, traits considered beneficial for viruses. However, their mutation rates are almost disastrously high, and a small increase in mutation rate can cause RNA viruses to go locally extinct. Researchers often assume that natural selection has optimized the mutation rate of RNA viruses, but new data shows that, in poliovirus, selection for faster replication is stronger and faster polymerases make more mistakes. The fabled mutation rates of RNA viruses appear to be partially a consequence of selection on another trait, not because such a high mutation rate is optimal in and of itself.
Mutations are the building blocks of most of evolution—they are the variation upon which natural selection can act, and they are the cause of much of the novelty we see occur in evolution. However, most mutations are not beneficial for the organisms with them. Many mutations cause organisms to leave fewer descendants over time, so the action of natural selection on these mutations is to purge them from the population. While a small percentage of mutations are helpful and some are inconsequential (neutral or nearly neutral in effect), a large portion of mutations are harmful. While the fraction of mutations that are harmful versus beneficial may change in different organisms, in different environments, and over time, deleterious mutations are thought to always outnumber beneficial mutations. That remains true whether an organism has a low mutation rate or a high mutation rate, and biological entities differ dramatically in their per-nucleotide mutation rate (over eight orders of magnitude, Fig 1).
Mutation rates are evolvable and can respond to selection
In some cases, there is no benefit to mutation at all. At an extreme, an organism that’s “perfectly” adapted to its constant environment would do best to reduce its mutation rate to zero—there are no more beneficial mutations, so all mutations are likely worse than the current genotype (see C in Fig 2). In a constant environment (one where the fitness landscape does not change), it would be best for the optimal genotype to not mutate at all. At another extreme, if an organism is suddenly thrust into an environment that it’s not well adapted to (akin to being at A in Fig 2), there is a larger fraction of potentially beneficial mutations available and having a nonzero mutation rate would be preferable to all descendants always staying exactly the same. The more variable the environments an organism experiences and the lower fitness the organism is in those environments, the more an increased mutation rate would be favored since there is a greater chance per mutation of a mutation being beneficial.
Organisms may not be able to change the fraction of mutations that are deleterious, but they do have some control over their mutation rates, which can limit the number of deleterious mutations that will plague their descendants. Of course, a lower mutation rate comes with the tradeoff that it will also limit the smaller fraction of beneficial mutations—alleles that are beneficial in the current environment and that will help an organism leave more descendants over time. It would also limit the accumulation of neutral (or nearly neutral) variation in populations that might be beneficial if circumstances change, alleles that could be beneficial in a new environment or after climactic change. The mutation rate of all cellular life is under selection, and cells have evolved many ways of tweaking their mutation rates—largely to lower the mutation rate inherent in a fast-moving, processive polymerase replicating their large genomes. These involve proofreading components of the polymerases themselves and a variety of other proteins and systems to check for errors in DNA and to repair common kinds of DNA damage. Some DNA viruses with larger genomes also have DNA repair proteins, and the very largest RNA viruses have some ability to proofread and correct replication errors. Mutant viruses and cells with lowered mutation rates can be isolated by exposing cells or viruses to mutagens, but just as there are proteins and alleles that decrease mutation rates, there are mutations to break those proteins and other alleles that increase mutation rates, which are beneficial in some environments.
RNA viruses are perhaps the most intriguing biological entities in which to study mutation rates. They encode their replication machinery, and thus their mutation rates can be optimized for their fitness (in comparison to small DNA viruses that use the polymerases of their host cells). Their inherently high mutation rates yield offspring that differ by 1–2 mutations each from their parent, producing a mutant cloud of descendants that complicates our conception of a genotype’s fitness. Their ability to rapidly change their genome underlies their ability to emerge in novel hosts, escape vaccine-induced immunity, and evolve to circumvent disease resistance engineered or bred into our crops. On the other hand, their mutation rates are an exploitable Achilles’ heel: researchers and clinicians can increase RNA virus mutation rates using nucleoside analogues, and a 3–5-fold increase in mutation rate causes lethal mutagenesis in human-infecting viruses like poliovirus and influenza. The exogenous mutagen causes enough additional mutations, which are often deleterious, so that the progeny RNA viruses are of lower fitness, eventually leading to ecological collapse of the population. Another way in which researchers have seen the constraints imposed by the high mutation rate of RNA viruses is in their limited genome size—the mutation rates per nucleotide are too high to increase their genome size without having a higher per-genome accumulation of mutations. Researchers have suggested that RNA virus mutation rates have evolved to be just under the threshold for lethal mutagenesis (sometimes referred to as error threshold) but that selection for genetic diversity and other consequences of a high mutation rate push RNA viruses to near their catastrophic limits. It has been hard to assess this assumption and verify that RNA viruses have their optimal mutation rates due to natural selection on mutation rate.
Poliovirus mutation rate and fidelity
One of the best-studied systems for RNA virus mutation is poliovirus, in which a now frequently used lower mutation rate mutant (G64S in the 3D RNA-dependent RNA polymerase, 3D:G64S) was characterized, simultaneously, by virologists working at two locations in the San Francisco Bay Area. The 3D:G64S strains not only have a lower mutation rate than wild-type polio but also are less fit in several ways: in one-step growth curves, in cell culture passaging, and in mice, in which they have reduced virulence (the 3D:G64S strains more slowly invade the central nervous system). They are more fit than wild-type poliovirus only in the presence of mutagens, in which their lower mutation rate reduces the inherent number of mutations in each progeny genome, so more exogenous mutations can be tolerated. The 3D:G64S strain also has measurably less genetic diversity during infections, which has suggested a link between population diversity and virulence as well as the adaptability that is conferred by having more standing genetic variation and being able to more rapidly create more variation. However, these conclusions are largely correlational and theoretical, as it has been difficult to conduct experiments to definitively prove that it is indeed the reduced mutation rate of 3D:G64S and not other effects of this mutation causing the reduced virulence and fitness observed in experiments.
In this issue of PLOS Biology, Fitzsimmons and colleagues show that reduced replication speed explains more of the effects of the 3D:G64S than its reduced mutation rate per se. There is an intuitive link between replication speed and mutational fidelity—it’s easier for anyone or anything to complete a repetitive task if one can tolerate a certain level of mistakes. If a task is critical to do without any errors at all, it will likely need to be done more slowly with more care and attention. That slower/more accurate relationship has been suggested by previous, less sequencing-intensive work, but not all mutations in poliovirus obligately affect both replication speed and mutational fidelity. Fitzsimmons and colleagues demonstrate that a compensatory mutation in 3D:G64S can restore replication speed but not affect the lower mutation rate of 3D:G64S, and this increases viral fitness (2C:V127L). This key experiment teased apart two highly correlated traits to reveal that replication rate affects fitness more than mutation rate.
Further, Fitzsimmons and colleagues cast doubt on the wild type’s advantage of genetic diversity for virulence. The process of entering the mouse central nervous system is a severe bottleneck and is dominated by drift compared to selection—both the wild type and 3D:G64S polioviruses have similar diversities in the mouse central nervous system. Deep sequencing of cell culture-passaged wild type and 3D:G64S populations revealed that both lacked genetic diversity at a meaningful level (SNPS at 0.1%). Finally, the wild type and 3D:G64S increased fitness by identical amounts after passaging in cell culture, refuting that the lower mutation rate of the 3D:G64S strain reduces adaptability. Altogether, this new work suggests that the 3D:G64S strain has a lower fitness because of slower replication, not its reduced mutation rate. RNA viruses like poliovirus likely have higher mutation rates than what would be optimal for the organism because higher mutation rates are, in part, a byproduct of selection for faster genomic replication.
This deeper dive into RNA virus replication fidelity will focus researchers on the consequences of RNA viruses coping with higher than desired mutation rates. This makes the clinical uses of lethal mutagenesis easier to understand—the small increases in mutation rate are not knocking RNA viruses off an optimal peak but are a further insult to an already nearly intolerable mutation rate. Also, just as bacterial populations are known to house mutation rate polymorphisms, this work should strengthen the nascent field of understanding mutation rate variation within RNA viral populations. Additionally, replication time (generation time) may be a larger component of understanding virus evolvability than it has been given credit for—likely undervalued because of the difficulties in measuring that trait in multicellular organisms.
RNA viruses have high mutation rates, but they may tolerate them rather than revel in them. That they were optimized for genetic variation alone is a “just so story” that should be skeptically re-examined as the more complicated biological reality is revealed.
References 26
- 1.
Baer CF. Does mutation rate depend on itself. PLoS Biol. 2008;6(2):e52
Not in our library10.1371/journal.pbio.0060052
- 2.
Loewe L, Hill WG. The populations of mutations: good, bad and indifferent. Philosophical transactions of the Royal Society of London. 2010;365(1544):1153–67.
Not in our library10.1098/rstb.2009.0317
- 3.
Gago S, Elena SF, Flores R, Sanjuan R. Extremely high mutation rate of a hammerhead viroid. Science. 2009;323(5919):1308.
Not in our library10.1126/science.1169202
- 4.
Flores R, Serra P, Minoia S, Di Serio F, Navarro B. Viriods: from genotype to phenotype just relyin on RNA sequence and structural motifs. Frontiers in microbiology. 2012;3:217
Not in our library10.3389/fmicb.2012.00217
- 5.
Barrett RDH, Schluter D. Adaptation from standing genetic variation. Trends Ecol Evol. 2008;23(1):38–44.
Not in our library10.1016/j.tree.2007.09.008
- 6.
Spampinato. Protecting DNA from errors and damage: an overview of DNA repair mechanisms in plants compared to animals. Cellular and Molecular Life Science. 2017;74(9):1693–709.
Not in our library10.1007/s00018-016-2436-2
- 7.
Smith EC, Denison MR. Coronaviruses as DNA wannabes: A new model for the regulation of RNA irus replication fidelity PLoS Pathog. 2013;9(12):e1003760
Not in our library10.1371/journal.ppat.1003760
- 8.
Couce A, Viraphong Caudwell L, Feinauer C, Hindré T, Feugeas J-P, Weigt M, et al Mutator genomes decay, despite sustained fitness gains, in a long-term experiment with bacteria. Proc Natl Acad Sci U S A. 2017;114(43):e9026–e35.
Not in our library10.1073/pnas.1705887114
- 9.
Vignuzzi M, Andino R. Closing the gap: the challenges in converging theoretical, computational, experimental and real-life studies in virus evolution. Curr Opin Virol. 2012;2(5):515–8.
Not in our library10.1016/j.coviro.2012.09.008
- 10.
Vignuzzi M, Stone JK, Arnold JJ, Cameron CE, Andino R. Quasispecies diversity determines pathogenesis through cooperative interactions in a viral population. Nature. 2006;439(7074):344–8.
Not in our library10.1038/nature04388
- 11.
Lafforgue G, Martínez F, Sardanyés J, de la Iglesia F, Niu Q-W, Lin S-S, et al Tempo and mode of plant RNA virus escape from RNA interfence-mediated resistance. J Virol. 2011;85(19):9686–95.
Not in our library10.1128/jvi.05326-11
- 12.
Crotty S, Cameron CE, Andino R. RNA virus error catastrophe: Direct molecular test by using ribavirin. Proc Natl Acad Sci U S A. 2001;98(12):6895–900.
Not in our library10.1073/pnas.111085598
- 13.
Baranovich T, Wong S-S, Armstrong J, Marjuki H, Webby RJ, Webster RG, et al T-705 (Favipiravir) induces lethal mutagenesis in Influenza A H1N1 viruses in vitro. J Virol. 2013;87(7):3741–51.
Not in our library10.1128/jvi.02346-12
- 14.
Bull JJ, Sanjuan R, Wilke CO. Theory of lethal mutagenesis for viruses. J Virol. 2007;81(6):2930–9.
Not in our library10.1128/jvi.01624-06
- 15.
Belshaw R, Gardner A, Rambaut A, Pybus OG. Pacing a small cage: mutation and RNA viruses. Trends Ecol Evol. 2008;23(4):188–93.
Not in our library10.1016/j.tree.2007.11.010
- 16.
Biebricher CK, Eigen M. The error threshold. Virus Res. 2005;107(2):117–27.
Not in our library10.1016/j.virusres.2004.11.002
- 17.
Vignuzzi M, Stone JK, Andino R. Ribavirin and lethal mutagenesis of poliovirus: molecular mechanisms, resistance and biological implications. Virus Res. 2005;107(2):173–81.
Not in our library10.1016/j.virusres.2004.11.007
- 18.
- 19.
Fitzsimmons W, Woods RJ, McCrone JT, Woodman A, Arnold JJ, Yennawar M, et al A speed-fidelity trade-off determines the mutation rate and virulence of an RNA virus. PLoS Biol. 2018 16(6): e2006459
Not in our library10.1371/journal.pbio.2006459
- 20.
Regoes RR, Hamblin S, Tanaka MM. Viral mutation rates: modelling the roles of within-host viral dynamics and the trade-off between replication fidelity and speed. Proceedings of the Royal Society of London Series B, Containing papers of a Biological character. 2013;280(1750):1–9.
Not in our library10.1098/rspb.2012.2047
- 21.
Furio V, Moya A, Sanjuan R. The cost of replication fidelity in an RNA virus. Proc Natl Acad Sci U S A. 2005;102(29):10233–7.
Not in our library10.1073/pnas.0501062102
- 22.
de Visser JA. The fate of microbial mutators. Microbiology. 2002;148:1247–52.
Not in our library10.1099/00221287-148-5-1247
- 23.
Alexander HK, Mayer SI, Bonhoeffer S. Population heterogeneity in mutation rate increases the frequency of higher-order mutants and reduces long-term mutational load. Mol Biol Evol. 2017;34(2):419–36.
Not in our library10.1093/molbev/msw244
- 24.
Sanjuan R, Nebot MR, Chirico N, Mansky LM, Belshaw R. Viral mutation rates. J Virol. 2010;84(19):9733–48.
Not in our library10.1128/jvi.00694-10
- 25.
- 26.
Elena SF, Sanjuán R. Adaptive value of high mutation rates of RNA viruses: Separating causes from consequences. Journal of Virology. 2005;79(18):11555–8.
Not in our library10.1128/jvi.79.18.11555-11558.2005
Cited by papers we hold 13
- Chikungunya: a decade of burden in the Americas · 2024No notice
- A New HIV-1 K28E32-Reverse Transcriptase Variant Associated with the Rapid Expansion of CRF07_BC among Men Who Have Sex with Men · 2022Not checked
- SARS-CoV-2 Mutations and Their Impact on Diagnostics, Therapeutics and Vaccines · 2022No notice
- A Detailed Overview of Immune Escape, Antibody Escape, Partial Vaccine Escape of SARS-CoV-2 and Their Emerging Variants With Escape Mutations · 2022No notice
- The SARS-CoV-2 mutations versus vaccine effectiveness: New opportunities to new challenges · 2022No notice
- Meta-Analysis and Structural Dynamics of the Emergence of Genetic Variants of SARS-CoV-2 · 2021Not checked
- Virus Detection: A Review of the Current and Emerging Molecular and Immunological Methods · 2021No notice
- COVID-19: A Review on the Novel Coronavirus Disease Evolution, Transmission, Detection, Control and Prevention · 2021No notice
- Zoonotic origins of human coronaviruses · 2020No notice
- Could Vitamins Help in the Fight Against COVID-19? · 2020No notice
- SARS-CoV-2/COVID-19: Viral Genomics, Epidemiology, Vaccines, and Therapeutic Interventions · 2020No notice
- De novo design of potent and resilient hACE2 decoys to neutralize SARS-CoV-2 · 2020No notice
- Current Status of Epidemiology, Diagnosis, Therapeutics, and Vaccines for Novel Coronavirus Disease 2019 (COVID-19) · 2020No notice
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.